Valiant Laboratories Intrinsic Value
Valiant Laboratories (VALIANTLAB) median intrinsic value is ₹43.15 from 8 valuation models (range ₹32–₹136), vs current price ₹107.87 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Check VALIANTLAB company valuation to track the company's total market size over time.
VALIANTLAB Valuation Methods Summary — DCF, Graham Number & P/E
Valiant Laboratories intrinsic value across 8 models vs current price ₹107.87 — upside/downside and value range per method. For current market price and key ratios, visit VALIANTLAB share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹32.36 | ₹25.89 - ₹38.83 | -70.0% | EPS: ₹1.28, Sector P/E: 22x |
| Book Value Method | asset | ₹115.19 | ₹103.67 - ₹126.71 | +6.8% | Book Value/Share: ₹57.59, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹136.30 | ₹122.67 - ₹149.93 | +26.4% | Revenue/Share: ₹68.15, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹43.15 | ₹38.84 - ₹47.47 | -60.0% | EBITDA: ₹20.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹43.15 | ₹34.52 - ₹51.78 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹32.36 | ₹29.12 - ₹35.60 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹32.36 | ₹29.12 - ₹35.60 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹40.73 | ₹36.66 - ₹44.80 | -62.2% | EPS: ₹1.28, BVPS: ₹57.59 |
VALIANTLAB Intrinsic Value vs Market Price — All Valuation Models
Valiant Laboratories fair value range ₹32–₹136 vs current market price ₹107.87 across 8 valuation models. See VALIANTLAB book value comparison to compare market price against book value per share.
VALIANTLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Valiant Laboratories median intrinsic value ₹43.15, current price ₹107.87 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of VALIANTLAB?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Valiant Laboratories (VALIANTLAB) is ₹43.15 (median value). With the current market price of ₹107.87, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹32.36 to ₹136.30, indicating ₹32.36 - ₹136.30.
Is VALIANTLAB undervalued or overvalued?
Based on our multi-method analysis, Valiant Laboratories (VALIANTLAB) appears to be trading above calculated value by approximately 60.0%.
VALIANTLAB Financial Health — Key Ratios vs Industry Benchmarks
Valiant Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.71 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 2.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
VALIANTLAB Cash Flow Quality — Operating & Free Cash Flow
Valiant Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1 Cr | ₹-26 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹2 Cr | ₹-70 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹56 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |